Drug-Induced Gynecomastia: Data Mining and Analysis of the FDA Adverse Event Reporting System Database
Introduction Gynecomastia, classified as a benign endocrine disorder, is distinguished by the proliferation of glandular breast tissue and the concomitant deposition of adipose tissue in males, culminating in a discernible alteration of breast morphology …